Deloitte Launches FastForward™ for Life Sciences, an Agentforce-Powered Customer Relationship Management Accelerator
Offering is designed to enhance time to value, provide a predictable cost model and to accelerate the path to Agentforce-driven pharma-readiness SAN FRANCISCO, Sept. 14, 2026 /PRNewswire/ -- Deloitte today announced an expansion of its strategic alliance with Salesforce by launching...
Covered in this story
What has happened since
- Salesforce is down 6.6% since this was published, 36 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Salesforce
- Bank of America: $241 → $285 by Oct 2027 · Buy via Seeking Alpha
- Bank of America: $229 → $285 by Oct 2027 · Buy via Investing.com
- Oppenheimer: $225 → $275 by Sep 2027 · Outperform via Investing.com UK
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CRM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Salesforce →Dalsna Finance is currently tracking 45 stories mentioning Salesforce, the earliest published 27 May 2026.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.